Camelid VHH Antibodies that Neutralize Botulinum Neurotoxin Serotype E Intoxication or Protease Function

被引:17
|
作者
Tremblay, Jacqueline M. [1 ]
Vazquez-Cintron, Edwin [2 ]
Lam, Kwok-Ho [3 ]
Mukherjee, Jean [1 ]
Bedenice, Daniela [4 ]
Ondeck, Celinia A. [2 ]
Conroy, Matthieu T. [2 ]
Bodt, Skylar M. L. [2 ]
Winner, Brittany M. [2 ]
Webb, Robert P. [5 ]
Ichtchenko, Konstantin [6 ]
Jin, Rongsheng [3 ]
McNutt, Patrick M. [2 ]
Shoemaker, Charles B. [1 ]
机构
[1] Tufts Univ, Cummings Sch Vet Med, Dept Infect Dis & Global Hlth, North Grafton, MA 01536 USA
[2] US Army, Med Res Inst Chem Def, Aberdeen Proving Ground, MD 21010 USA
[3] Univ Calif Irvine, Dept Physiol & Biophys, Irvine, CA 92697 USA
[4] Tufts Univ, Cummings Sch Vet Med, Dept Clin Sci, North Grafton, MA 01536 USA
[5] US Army, Med Res Inst Infect Dis, Bacteriol Div, Ft Detrick, MD 21702 USA
[6] NYU, Sch Med, Dept Biochem & Mol Pharmacol, New York, NY 10016 USA
关键词
botulinum neurotoxin; botulism; toxin; antitoxin; single-domain antibody; VHH; neutralization; protease; SINGLE; BINDING; NANOBODIES; AGENTS; CHALLENGE; PROTECTS; DOMAINS; TOXINS; MICE; PH;
D O I
10.3390/toxins12100611
中图分类号
TS2 [食品工业];
学科分类号
0832 ;
摘要
Botulinum neurotoxin (BoNT) serotype E is one of three serotypes that cause the preponderance of human botulism cases and is a Tier 1 Select Agent. BoNT/E is unusual among BoNT serotypes for its rapid onset and short duration of intoxication. Here we report two large panels of unique, unrelated camelid single-domain antibodies (VHHs) that were selected for their ability to bind to BoNT/E holotoxin and/or to the BoNT/E light chain protease domain (LC/E). The 19 VHHs which bind to BoNT/E were characterized for their subunit specificity and 8 VHHs displayed the ability to neutralize BoNT/E intoxication of neurons. Heterodimer antitoxins consisting of two BoNT/E-neutralizing VHHs, including one heterodimer designed using structural information for simultaneous binding, were shown to protect mice against co-administered toxin challenges of up to 500 MIPLD50. The 22 unique VHHs which bind to LC/E were characterized for their binding properties and 9 displayed the ability to inhibit LC/E protease activity. Surprisingly, VHHs selected on plastic-coated LC/E were virtually unable to recognize soluble or captured LC/E while VHHs selected on captured LC/E were poorly able to recognize LC/E coated to a plastic surface. This panel of anti-LC/E VHHs offer insight into BoNT/E function, and some may have value as components of therapeutic antidotes that reverse paralysis following BoNT/E exposures.
引用
收藏
页数:18
相关论文
共 50 条
  • [41] Glycine insertion at protease cleavage site of SNAP25 resists cleavage but enhances affinity for botulinum neurotoxin serotype A
    Ho, Mengfei
    Goh, Cheong-Hian
    Brothers, Michael C.
    Wang, Shihua
    Young, Ryan L.
    Ou, Yuxiang
    Lui, Juliana Nga-Man
    Kalafatis, Marinos
    Lan, Xiuwan
    Wolf, Abigail E.
    Rienstra, Chad M.
    Wilson, Brenda A.
    PROTEIN SCIENCE, 2012, 21 (03) : 318 - 326
  • [42] DEVELOPMENT AND CHARACTERIZATION OF A CELL-BASED ASSAY FOR RELATIVE POTENCY TESTING OF BOTULINUM NEUROTOXIN SEROTYPE E
    Piazza, Timothy M.
    Geurs, Theresa L.
    Hendrickson, Sara B.
    Dunning, F. Mark
    Tucker, Ward C.
    TOXICON, 2021, 190 : S59 - S60
  • [43] Vaccination of Rabbits with an Alkylated Toxoid Rapidly Elicits Potent Neutralizing Antibodies against Botulinum Neurotoxin Serotype B
    Held, Daniel M.
    Shurtleff, Amy C.
    Fields, Scott
    Green, Christopher
    Fong, Julie
    Jones, Russell G. A.
    Sesardic, Dorothea
    Buelow, Roland
    Burke, Rae Lyn
    CLINICAL AND VACCINE IMMUNOLOGY, 2010, 17 (06) : 930 - 936
  • [44] Neutralizing Antibodies of Botulinum Neurotoxin Serotype A Screened from a Fully Synthetic Human Antibody Phage Display Library
    Yu, Rui
    Wang, Shuang
    Yu, Yun-zhou
    Du, Wei-shi
    Yang, Fang
    Yu, Wei-yuan
    Sun, Zhi-wei
    JOURNAL OF BIOMOLECULAR SCREENING, 2009, 14 (08) : 991 - 998
  • [45] Biology activity and characterization of the functional L-HN fragment derivative of botulinum neurotoxin serotype E
    Tan, Xiao
    Zhang, Cong-Cong
    Lu, Jian-Sheng
    Li, Zhi-Ying
    Li, Bo-Lin
    Liu, Xu-Yang
    Yu, Yun-Zhou
    Xu, Qing
    ANAEROBE, 2023, 82
  • [46] The Receptor Binding Domain of Botulinum Neurotoxin Serotype A (BoNT/A) Inhibits BoNT/A and BoNT/E Intoxications In Vivo
    Ben David, Alon
    Diamant, Eran
    Barnea, Ada
    Rosen, Osnat
    Torgeman, Amram
    Zichel, Ran
    CLINICAL AND VACCINE IMMUNOLOGY, 2013, 20 (08) : 1266 - 1273
  • [47] Genetically engineered red cells expressing single domain camelid antibodies confer long-term protection against botulinum neurotoxin
    Huang, Nai-Jia
    Pishesha, Novalia
    Mukherjee, Jean
    Zhang, Sicai
    Deshycka, Rhogerry
    Sudaryo, Valentino
    Dong, Min
    Shoemaker, Charles B.
    Lodish, Harvey F.
    NATURE COMMUNICATIONS, 2017, 8
  • [48] Post-Intoxication Inhibition of Botulinum Neurotoxin Serotype A within Neurons by Small-Molecule, Non-Peptidic Inhibitors
    Ruthel, Gordon
    Burnett, James C.
    Nuss, Jonathan E.
    Wanner, Laura M.
    Tressler, Lyal E.
    Torres-Melendez, Edna
    Sandwick, Sarah J.
    Retterer, Cary J.
    Bavari, Sina
    TOXINS, 2011, 3 (03): : 207 - 217
  • [49] Genetically engineered red cells expressing single domain camelid antibodies confer long-term protection against botulinum neurotoxin
    Nai-Jia Huang
    Novalia Pishesha
    Jean Mukherjee
    Sicai Zhang
    Rhogerry Deshycka
    Valentino Sudaryo
    Min Dong
    Charles B. Shoemaker
    Harvey F. Lodish
    Nature Communications, 8
  • [50] PROTEASE ACTIVITY OF BOTULINUM NEUROTOXIN TYPE-E AND ITS LIGHT CHAIN - CLEAVAGE OF ACTIN
    DASGUPTA, BR
    TEPP, W
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1993, 190 (02) : 470 - 474